Taler Sandra J
Division of Nephrology and Hypertension, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA.
Curr Hypertens Rep. 2009 Feb;11(1):23-8. doi: 10.1007/s11906-009-0006-9.
Systolic blood pressure is higher in African American and Hispanic women older than 60 and in white women older than 70 than it is in men. Coupled with their longer survival, elderly women have higher hypertension prevalence rates, particularly for isolated systolic hypertension. Hemodynamic characteristics differ by sex for premenopausal women and age-matched men, but these differences lessen after menopause. This transition may result from hormonal or metabolic alterations, including weight gain and tissue adiposity, which are common after menopause. Clinical trials enrolling large numbers of women support the benefits of treatment to reduce cardiovascular events and mortality. The trend to enroll subjects with several comorbidities and thereby increase event rates may limit the applicability of trial results to healthier women. Women appear more prone to develop side effects from antihypertensive medications and may metabolize these agents differently. There is a need for additional studies regarding appropriate drug selection, dosage, and combination therapy for women.
60岁以上的非裔美国女性和西班牙裔女性以及70岁以上的白人女性的收缩压高于男性。老年女性寿命更长,高血压患病率更高,尤其是单纯收缩期高血压。绝经前女性和年龄匹配的男性的血流动力学特征存在性别差异,但绝经后这些差异会减小。这种转变可能是由激素或代谢改变引起的,包括体重增加和组织肥胖,这些在绝经后很常见。纳入大量女性的临床试验支持治疗对减少心血管事件和死亡率的益处。纳入患有多种合并症的受试者从而提高事件发生率的趋势可能会限制试验结果对健康女性的适用性。女性似乎更容易出现抗高血压药物的副作用,并且可能对这些药物的代谢方式不同。需要针对女性进行更多关于合适药物选择、剂量和联合治疗的研究。